Compare ORRF & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORRF | PSNL |
|---|---|---|
| Founded | 1919 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 734.3M | 746.8M |
| IPO Year | N/A | 2019 |
| Metric | ORRF | PSNL |
|---|---|---|
| Price | $37.57 | $8.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $42.00 | $11.33 |
| AVG Volume (30 Days) | 283.3K | ★ 1.4M |
| Earning Date | 01-27-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.19% | N/A |
| EPS Growth | ★ 182.43 | N/A |
| EPS | ★ 4.18 | N/A |
| Revenue | ★ $252,079,000.00 | $69,103,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.51 | $19.41 |
| P/E Ratio | $9.00 | ★ N/A |
| Revenue Growth | ★ 43.11 | N/A |
| 52 Week Low | $25.57 | $2.83 |
| 52 Week High | $40.72 | $11.50 |
| Indicator | ORRF | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 49.71 | 47.65 |
| Support Level | $36.81 | $7.95 |
| Resistance Level | $40.72 | $9.04 |
| Average True Range (ATR) | 1.04 | 0.71 |
| MACD | -0.04 | -0.10 |
| Stochastic Oscillator | 42.88 | 39.47 |
Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.